Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Asker Healthcare Group ABOSTO:ASKER -2.23%13 EV-to-EBITDA is 26.34 as of Aug. 11, 2026, which is 6% below its 10-year median of 28.02. GuruFocus rates OSTO:ASKER with a GF Score™ of 13/100. The stock has 2 warning signs investors should review. Among 99 Medical Distribution companies, Asker Healthcare Group AB ranks worse than 90.91% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Asker Healthcare Group AB's enterprise value is kr36,823 Mil.
Asker Healthcare Group AB's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was kr1,398 Mil. Therefore, Asker Healthcare Group AB's EV-to-EBITDA for today is 26.34.
The historical rank and industry rank for Asker Healthcare Group AB's EV-to-EBITDA or its related term are showing as below:
OSTO:ASKER'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 21.93 Med: 28.02 Max: 35.59
Current: 26.33
During the past 4 years, the highest EV-to-EBITDA of Asker Healthcare Group AB was 35.59. The lowest was 21.93. And the median was 28.02.
OSTO:ASKER's EV-to-EBITDA is ranked worse than 90.91% of 99
companies
in the Medical Distribution industry
Industry Median: 8.52
vs OSTO:ASKER: 26.33
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Asker Healthcare Group AB (OSTO:ASKER) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Asker Healthcare Group AB's PE Ratio (TTM) for today is calculated as:
Asker Healthcare Group AB's share price for today is kr81.15.
Asker Healthcare Group AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1.780.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ASKER vs MCK, COR, CAH: EV-to-EBITDA Comparison
For the Medical Distribution subindustry, Asker Healthcare Group AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asker Healthcare Group AB EV-to-EBITDA vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Asker Healthcare Group AB's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Asker Healthcare Group AB's EV-to-EBITDA falls into.
Asker Healthcare Group AB's current Enterprise Value is kr36,823 Mil.
Asker Healthcare Group AB's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,398 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asker Healthcare Group AB (OSTO:ASKER) has a EV-to-EBITDA of 26.34 as of Aug. 11, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Asker Healthcare Group AB. This is near median its historical median of 28.02. Over the past decade, Asker Healthcare Group AB's EV-to-EBITDA has ranged from 21.93 to 35.59. According to the industry distribution chart, Asker Healthcare Group AB ranks #90 out of 99 companies in the Medical Distribution industry, placing it in the top 90.9%.
Is Asker Healthcare Group AB's EV-to-EBITDA too high?
Asker Healthcare Group AB's current EV-to-EBITDA of 26.34 is near median its 10-year median of 28.02. Over the past 10 years, this metric has ranged from a low of 21.93 to a high of 35.59. The Medical Distribution industry median EV-to-EBITDA is 8.52. Asker Healthcare Group AB's value of 26.34 is 209.2% above this industry median. Based on the distribution chart, Asker Healthcare Group AB ranks #90 out of 99 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Asker Healthcare Group AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Asker Healthcare Group AB's EV-to-EBITDA compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Asker Healthcare Group AB ranks #90 out of 99 companies for EV-to-EBITDA. This places Asker Healthcare Group AB in the lower half of its industry. The industry median EV-to-EBITDA is 8.52. Asker Healthcare Group AB's value of 26.34 is 209.2% above this benchmark. Historically, Asker Healthcare Group AB's own EV-to-EBITDA has ranged from 21.93 to 35.59 over the past decade. While the company's 10-year median is 28.02 vs. the industry median of 8.52, Asker Healthcare Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Distribution company?
The median EV-to-EBITDA among Medical Distribution companies is 8.52, based on 99 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asker Healthcare Group AB's current EV-to-EBITDA of 26.34 is 209.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Asker Healthcare Group AB. For the Medical Distribution industry, the median EV-to-EBITDA is 8.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asker Healthcare Group AB's current EV-to-EBITDA is 26.34, which is near median its own 10-year median of 28.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asker Healthcare Group AB stock overvalued right now?
Asker Healthcare Group AB (OSTO:ASKER) has a current EV-to-EBITDA of 26.34. The current EV-to-EBITDA is 26.34, which is near median its 10-year median of 28.02 and 209.2% above the Medical Distribution industry median of 8.52. Asker Healthcare Group AB's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Asker Healthcare Group AB (OSTO:ASKER), the current EV-to-EBITDA is 26.34 as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability. Company has adapted a twin engine growth strategy that combines organic and acquired growth. Geographically, the company evaluates the operations in three business areas: North, West and Central.
13GF Score
Get the complete analysis for OSTO:ASKER
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ASKER has been successfully added to your 
